Reusable Surgical Drapes: Reprocessing Evidence to Verify Before Switching

The FDA regulation for surgical drapes, 21 CFR 878.4370, identifies a drape as a device made of natural or synthetic materials intended as a protective patient covering, such as to isolate a site of surgical incision from microbial and other contamination. It places the device in Class II with special controls. The current text exempts a surgical drape that does not include an antimicrobial agent from premarket notification, subject to the limitations in 21 CFR 878.9. The regulation says nothing about single use versus reuse. A woven reusable drape and a nonwoven disposable drape sit under the same classification.

Reusable drape lines have also gone through 510(k) review. In November 2008, FDA found SRI/Surgical Express Level IV Drapes substantially equivalent under 878.4370, product code KKX (K080796). The indications describe them as reusable drapes, including back table covers, Mayo stand covers, and drape sheets. Two lessons follow. First, reusable lines have been cleared under a name that claims the top barrier level, so reuse does not by itself imply a lower barrier claim. Second, a 2008 clearance letter does not tell you today's labeled cycle limit or test data. Those live in the current labeling and the manufacturer's files, so ask for them directly.

In regulatory terms, what makes a drape reusable is its labeling. FDA's 1993 guidance on 510(k) submissions for surgical gowns and surgical drapes asks that labeling for drapes offered as reusable include instructions on how to reprocess the device, including laundering and sterilization information, the number of reprocessings the drape can withstand, and a system for keeping track of reuse cycles. The same guidance lists durability as a mechanical specification: the number of times the device can be laundered and sterilized and still meet its specifications using the sterilization method in its labeling.

FDA's March 2015 guidance, Reprocessing Medical Devices in Health Care Settings: Validation Methods and Labeling, applies the same logic to reusable devices generally. It recommends that manufacturers formulate and scientifically validate reprocessing instructions and describes what premarket submissions should contain about them; health care facilities then carry out those instructions. FDA's guidance page also notes that exemption from 510(k) does not exempt a device from labeling or Quality Management System Regulation (QMSR) requirements. Guidance documents are nonbinding recommendations, but the practical point for a buyer is plain: a 510(k)-exempt drape sold as reusable still needs instructions and labeling that support the reuse claim.

FDA's webinar material on surgical gown 510(k)s adds the testing expectation. For gowns intended to be reusable, barrier performance testing should also be performed at the end of the labeled use-life, meaning the maximum reprocessing cycles. The review items for reusable products include laundering instructions, a recommended number of uses, and a method for tracking the number of uses. Those slides are worded for gowns, but they show how FDA reviewers approach reusable barrier textiles, and they line up with the drape labeling items in the 1993 guidance.

A reusable drape program is a closed loop: the drape leaves the operating room soiled and comes back sterile. Each stage has its own controlling document, and a gap at any stage undermines the barrier claim you paid for.

Used drapes soiled with blood or other potentially infectious materials are contaminated laundry under OSHA's bloodborne pathogens standard, 29 CFR 1910.1030(d)(4)(iv). Contaminated laundry must be handled as little as possible with a minimum of agitation. It must be bagged or containerized at the location where it was used and must not be sorted or rinsed there. Bags or containers must be labeled or color-coded as the standard requires, and wet laundry with a reasonable likelihood of soak-through or leakage must go in bags or containers that prevent it. Employees who handle contaminated laundry must wear protective gloves and other appropriate personal protective equipment. Laundry shipped to an off-site facility that does not use Universal Precautions must travel in labeled or color-coded containers.

CDC's environmental infection control guideline gives the reason for minimal agitation: it helps prevent potentially contaminated lint aerosols in patient-care areas. For a buyer, this adds a collection and return route, staff training, and operating cost to the reusable program. Include that route in the laundry contract and the facility plan.

CDC's laundry guidance, drawn from the 2003 HICPAC environmental infection control guideline, lists drapes for surgical procedures among health care laundry and describes these parameters:

• Hot-water washing: a temperature of at least 160°F (71°C) for a minimum of 25 minutes is commonly recommended.

• Chlorine bleach: a total available chlorine residual of 50 to 150 ppm is usually achieved during the bleach cycle.

• Low-temperature washing: studies show water at 71°F to 77°F (22°C to 25°C) can reduce microbial contamination when washer cycling, detergent, and additive amounts are carefully monitored and controlled. These cycles rely heavily on chlorine- or oxygen-activated bleach, and CDC says oxygen-based bleach and detergents used in health care settings should be registered by EPA.

• Fabric instructions: CDC tells health care workers to note the cleaning instructions of textiles, drapes, and clothing to identify special laundering requirements. For reusable drapes, that is where the manufacturer's reprocessing instructions take over from generic laundry practice.

These are general CDC laundry descriptions, not a validated recipe for your drape. Check the contractor's wash formula against the exact manufacturer's instructions, including permitted chemistry and equipment. A generic temperature claim cannot establish that a particular drape retains its labeled barrier performance.

CDC also states that, in the absence of microbiologic standards for laundered textiles, there is no rationale for routine microbiologic sampling of cleaned health care textiles; sampling belongs in outbreak investigations. The evidence a buyer can expect from a laundry is therefore process evidence, such as wash formulas, temperatures, chemistry, and batch records, not routine culture results.

ANSI/AAMI ST65:2008/(R)2018, Processing of reusable surgical textiles for use in health care facilities, is the recommended practice that ties the chain together. FDA recognizes the complete standard (recognition number 14-286, entered July 2014, Sterility specialty task group) and lists 21 CFR 878.4370 among its related regulations, alongside the gown regulations. According to FDA's recognition record, ST65 covers the handling, processing, and preparation of reusable surgical textiles on-site or off-site, including design criteria for work areas; staff qualifications, education, and training; receiving and handling of soiled textiles; laundry processing; transport of soiled and clean textiles; installation, care, and maintenance of laundry equipment; quality control; and regulatory considerations.

AAMI sells the full standard, so this guide does not reproduce its requirements. Several CDC points sit alongside it and are easy to check on a site visit. A laundry is usually partitioned into a dirty area for receiving and handling soiled laundry and a clean area for processing washed items. Areas receiving contaminated textiles should be at negative air pressure relative to clean areas. Clean and contaminated textiles should travel in vehicles that keep them separated, physically or by space separation verified to be effective.

After washing and drying, each drape has to be checked before it goes back into a pack. Field data compiled for a 2018 life cycle assessment (LCA) of surgical drapes describe what reusable-drape laundries do at this point. Cleaned and dried drapes are inspected and tested. Visual inspection with light identifies physical damage, which is then repaired. Testing identifies drapes with inadequate barrier performance, and those failed items are removed from service. About 2 percent of drapes are not adequately clean after one cycle and are rewashed. Most of these plants use a tracking system to flag drapes that have reached their design life.

Repair rules should come from the drape's manufacturer, because a repair changes the material in the barrier. Ask whether repairs are allowed in the critical zone, what method and material are used, whether there is a limit on repairs per drape, and how repaired drapes are tested. The drape is then folded, packed, and sterilized. In the LCA's modeled system, the laundry sterilized the drapes with a dynamic-air-removal steam cycle before delivery and packed each one in a new disposable primary bag. Whatever method your program uses should be the one in the drape's labeling, and the packaging should match that validated process, a principle our guide to self-seal versus heat-seal sterilization pouches explains for pouch selection.

flowchart TD
    A["Used drape at end of case"] -->|"OSHA: bag at point of use, minimal agitation, no sorting or rinsing"| B["Identify containers; prevent leakage when soak-through is likely"]
    B --> C["Soiled receiving area; CDC recommends negative pressure to clean areas"]
    C --> D["Wash by manufacturer instructions; record processing events"]
    D --> E["Dry and inspect; check barrier-test evidence required by the program"]
    E -->|"Not adequately clean"| D
    E -->|"Damage found"| F{"Repair allowed by manufacturer?"}
    F -->|"Yes"| G["Repair by the manufacturer's method"]
    G --> E
    F -->|"No"| X["Remove from service"]
    E -->|"Failed required barrier test"| X
    E -->|"Acceptable"| H{"Next sterilization and use within labeled life?"}
    H -->|"No, or count cannot be verified"| X
    H -->|"Yes"| I["Fold, pack, sterilize by labeled method; record event"]
    I --> J["Release only after required checks; sterile storage and delivery"]
    J --> A

In the United States, liquid barrier claims for drapes are classified under ANSI/AAMI PB70:2022, Liquid barrier performance and classification of protective apparel and drapes intended for use in health care facilities. PB70 has four levels. FDA's gown-review slides, citing the 2003 edition and an acceptable quality limit of 4 percent, summarize them this way:

• Level 1: AATCC 42 impact penetration of 4.5 g or less.

• Level 2: AATCC 42 of 1.0 g or less, plus AATCC 127 hydrostatic pressure of at least 20 cm.

• Level 3: AATCC 42 of 1.0 g or less, plus AATCC 127 hydrostatic pressure of at least 50 cm.

• Level 4: FDA's slides identify a pass/fail ASTM F1671 penetration test for gowns. They do not establish the drape test method. Require the supplier to identify the drape-specific method and edition in its report, then check these against the PB70 edition in your contract. Our surgical drapes specification guide explains the product-type distinction.

Check the PB70 edition named in each test report against the edition your contract cites. CDC also notes that data are limited on the link between gown or drape characteristics and surgical site infection risk, so a barrier level is a specification, not a clinical outcome claim. Choosing the level for a given procedure is a decision for the facility's perioperative and infection prevention leads. Procurement's job is to confirm that the level claimed is still true at the end of the drape's labeled life.

A drape is not uniform. FDA's gown-review material asks for drawings that show the location of critical and non-critical zones, and European standards build the same split into their requirements. EN 13795-1 covers single-use and reusable surgical drapes and gowns used as medical devices. A procurement technical sheet from MSF Supply summarizes its rules: the manufacturer must tell the user the performance level, standard or high, and identify critical and less critical product areas; if no differentiation is made, all areas must meet the critical-area requirements. The tests include liquid penetration (EN ISO 811) and wet bacterial penetration (EN ISO 22610).

A 2025 edition of EN 13795-1 has been published, while the MSF sheet summarizes the 2019 edition, so tie tender language to the edition your market requires. For reusable drapes, ask for the critical-zone map and the area-by-area results after the maximum number of processing cycles the manufacturer claims. Our sterile surgical gowns buying guide covers the same critical-zone evidence for gowns.

The National Academies' 2024 workshop proceedings on reusable health care textiles summarize the standards expectation for reusable protective products: they must denote the number of times they can be processed, include processing and inspection instructions, and demonstrate barrier performance after the number of laundering and sterilization processes indicated by their labeled use life. The ASTM specifications for reusable gowns, F2407 for surgical gowns and F3352 for isolation gowns, require physical-property testing after one laundering and sterilization cycle and again at the labeled use life. Our guide to isolation gowns and ASTM F3352 covers that apparel side.

Peer-reviewed data show why the end-of-life test matters and why it must be product-specific. A comparison of disposable and reusable medical gowns measured barrier performance in reusable Level 2 and Level 3 gowns after 1, 25, 50, and 75 industrial launderings. Impact penetration did not change significantly across wash intervals. Hydrostatic resistance told a different story: one Level 2 reusable brand showed a significant reduction in hydrostatic resistance at each interval tested (25, 50, and 75 launderings), the other Level 2 brand declined only after 75, and both Level 3 gowns held the maximum measured value throughout. Every reusable gown still met the minimum hydrostatic requirement after 75 launderings, so the declines show drift within a passing result, not failure. Earlier work by Leonas (1998), cited in the same paper, found that 50 commercial care cycles reduced the ability of reusable gown fabric to prevent bacterial transmission.

The study's barrier measurements are laundering results. They do not validate the complete washing-and-sterilization sequence for a surgical drape, and 75 washes in this study is not a labeled reuse limit for another product.

The lesson is not that reusable textiles always degrade, or that they never do. Results depend on the product and the property tested, so a supplier's general statement cannot stand in for data on the drape you are buying.

A labeled cycle limit only works if someone counts. FDA's 1993 guidance asks for “a system for keeping track of reuse cycles” in the labeling of reusable gowns and drapes. The reusable-gown specifications summarized by the National Academies call for an integral tracking mechanism, such as a grid for manual marking, an RFID chip, or a barcode, that stays functional for the labeled use life. HLAC's compendium notes that RFID and barcode tracking can help determine the remaining use life of key health care textiles, and that RFID systems can track location, last processing date, and losses.

Each method moves the work to a different place. A manual grid depends on someone marking every cycle. A barcode needs a scan at a defined step. RFID can be read without line of sight but needs readers and software, which the laundry rather than the hospital may own. For procurement, the questions are concrete: which step records the cycle, who owns the record, whether you can see it for each drape, and what happens when a drape reaches its limit.

Define the counter before comparing bids. Ask the manufacturer how its labeled limit accounts for initial processing, rewashing, and repeat sterilization, and require the laundry's item records to follow that definition. A count of completed cases may differ from a count of processing events. The LCA's rewash observation makes that distinction practical: extra processing can occur without another patient use. If a tag or record is missing, do not assign remaining life from an average; request a documented manufacturer-approved disposition.

The surgical drape LCA, prepared by Environmental Clarity for the European Chainge consortium and dated September 2018, offers a reality check. It reports that reusable surgical drapes are typically rated by the manufacturer for 75 to 100 uses before downgrade, but that the average use rate is always lower because of losses and damage. It therefore modeled 60 cycles as a conservative estimate based on industry data, a rate it describes as consistent with reusable surgical gowns.

Treat those numbers as context, not a target or a safe wash count. They describe one market's industry data and specific fabrics. Your planning number should start from the labeled limit on the drape you buy, then allow for losses, damage removals, and barrier-test failures, which your laundry should be able to report.

CDC notes that health care laundry may be done in-house, by a cooperative, or by an off-site commercial laundry, and that the textiles may be owned by the facility or by the processor under a rental arrangement. Whichever model you choose, the laundry runs part of the drape's validated process. The Healthcare Laundry Accreditation Council (HLAC) accredits laundries that process health care textiles. Its compendium ties accreditation to CDC/HICPAC guidance and OSHA bloodborne pathogen requirements, says its standards address the surgical pack assembly room based on ANSI/AAMI ST65, and recommends specifying HLAC accreditation in requests for proposal. Accreditation is voluntary and is not an FDA clearance. If a laundry is not accredited, ask for an ST65-based audit and its process records instead.

Write the evidence into the tender so that suppliers compete on the same documented basis. Claims such as “meets AAMI standards” or “reusable up to 70 washes” are starting points for questions, not specifications.

Lock the program in with a quality agreement. Fabric and finish changes matter for both product types. Reusable programs add wash chemistry, equipment, repair, and sterilization changes at the laundry. Require advance notice of those changes and a re-evaluation of the labeled cycle limit or barrier data when any of them occur. Our explainer on quality agreements for consumable suppliers covers the change-control and audit clauses.

Waste reduction is usually what starts the conversation, and the evidence supports it, with caveats. The 2018 LCA compared 1,000 uses of a representative reusable top drape, used 60 times each, with 1,000 single-use drapes, using European energy data. It modeled a 4 m² reusable drape at 576 g and a disposable drape at 245 g. These are drape-and-tape systems: the comparison includes tape, packaging, processing, transport, and end-of-life assumptions, rather than the fabric alone.

The blue-water figures measure net consumption under the report's accounting, not total water drawn by a laundry. The model excludes treated water returned to the environment and credits water recovered from soiled drapes. Its waste figure covers waste generated at the health care facility and excludes corrugated boxes assumed to be recycled; retired reusable fabric is modeled as reused or recycled. These boundaries matter when comparing the table with a contractor's metered water or waste invoices.

The same report shows where the reusable burden moves. About half of the reusable system's energy came from laundry, about 20 percent from drape manufacture, about 16 percent from packaging for transport between the laundry and the point of use, and about 9 percent from transport. For disposables, about 87 percent came from the drape manufacturing and supply-chain category, which includes transport to the kit packer and hospital. Reusables performed better in 10 of 11 impact categories, but ozone layer depletion was 36 percent higher for the reusable system, driven by emissions from producing the ePTFE used in the critical zone and the tape system.

Read those results with their limits. The study was commissioned by an industry consortium and reviewed by four consortium members. Its blue-water result carries significant uncertainty: in an extreme case of poor laundry efficiency, the reusable system could use up to 50 percent more blue water than disposables. It also applies only to the fabrics it modeled. Its sensitivity checks show what a buyer can influence: a 10 percent cut in laundry energy lowers the reusable system's energy use by about 5 percent, and a 10 percent lighter reusable drape lowers energy and blue water by about 8 percent.

Cost follows the same pattern. CDC notes that laundries are typically the largest users of hot water in hospitals, consuming 50 to 75 percent of the total and representing an average of 10 to 15 percent of a hospital's energy use. Its guidance tells facilities weighing gowns and drapes to consider the expense of disposable items and their waste-management cost against the costs of durable goods: the textiles themselves, staff to collect, sort, clean, and package them, and either the energy to run an on-site laundry or the price of an outside service. Every reusable cost is spread across the cycles a drape actually completes, which is why achieved life matters more than rated life.

The decision rule is simple to state. Reusable drapes make sense when the supplier can document the labeled limit and end-of-life barrier performance, the laundry can show ST65-aligned practice, and your program can count, inspect, sterilize, and retire every drape on time. If any of those is missing, the environmental and cost case is an estimate, not a result. For the specification fields that apply to every drape, reusable or not, see our surgical drapes specification guide. For storage and distribution conditions after sterilization, see labeled storage and transport for medical consumables.